Gene – gene interactions in the folate metabolic pathway influence the risk for acute lymphoblastic leukemia in children

References

• Kim Y I. Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer?. Cancer Epidemiol Biomarkers Prev 2004; 13: 511–519
   PubMed Web of Science ®Google Scholar
• Davis C D, Uthus E O. DNA methylation, cancer susceptibility, and nutrient interactions. Exp Biol Med (Maywood) 2004; 229: 988–995
   PubMed Web of Science ®Google Scholar
• Frosst P, Blom H J, Milos R, Goyette P, Sheppard C A, Matthews R G, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111–113
   PubMed Web of Science ®Google Scholar
• van der Put N M, Gabreels F, Stevens E M, Smeitink J A, Trijbels F J, Eskes T K, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. Am J Hum Genet 1998; 62: 1044–1051
   PubMed Web of Science ®Google Scholar
• Krajinovic M, Lamothe S, Labuda D, Lemieux-Blanchard E, Theoret Y, Moghrabi A, et al. Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood 2004; 103: 252–257
   PubMed Web of Science ®Google Scholar
• Skibola C F, Smith M T, Kane E, Roman E, Rollinson S, Cartwright R A, et al. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 1999; 96: 12810–12815
   PubMed Web of Science ®Google Scholar
• Kaneda S, Takeishi K, Ayusawa D, Shimizu K, Seno T, Altman S. Role in translation of a triple tandemly repeated sequence in the 5′-untranslated region of human thymidylate synthase mRNA. Nucleic Acids Res 1987; 15: 1259–1270
   PubMed Web of Science ®Google Scholar
• Horie N, Aiba H, Oguro K, Hojo H, Takeishi K. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5′-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct Funct 1995; 20: 191–197
   PubMed Web of Science ®Google Scholar
• Skibola C F, Smith M T, Hubbard A, Shane B, Roberts A C, Law G R, et al. Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood 2002; 99: 3786–3791
   PubMed Web of Science ®Google Scholar
• Hishida A, Matsuo K, Hamajima N, Ito H, Ogura M, Kagami Y, et al. Associations between polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and susceptibility to malignant lymphoma. Haematologica 2003; 88: 159–166
   PubMed Web of Science ®Google Scholar
• Krajinovic M, Costea I, Chiasson S. Polymorphism of the thymidylate synthase gene and outcome of acute lymphoblastic leukaemia. Lancet 2002; 359: 1033–1034
   PubMed Web of Science ®Google Scholar
• Iacopetta B, Grieu F, Joseph D, Elsaleh H. A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil. Br J Cancer 2001; 85: 827–830
   PubMed Web of Science ®Google Scholar
• Leclerc D, Campeau E, Goyette P, Adjalla C E, Christensen B, Ross M, et al. Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. Hum Mol Genet 1996; 5: 1867–1874
   PubMed Web of Science ®Google Scholar
• Harmon D L, Shields D C, Woodside J V, McMaster D, Yarnell J W, Young I S, et al. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol 1999; 17: 298–309
   PubMed Web of Science ®Google Scholar
• Gaughan D J, Kluijtmans L A, Barbaux S, McMaster D, Young I S, Yarnell J W, et al. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 2001; 157: 451–456
   PubMed Web of Science ®Google Scholar
• Jacques P F, Bostom A G, Selhub J, Rich S, Ellison R C, Eckfeldt J H, et al. Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study. Atherosclerosis 2003; 166: 49–55
   PubMed Web of Science ®Google Scholar
• Lincz L F, Scorgie F E, Kerridge I, Potts R, Spencer A, Enno A. Methionine synthase genetic polymorphism MS A2756G alters susceptibility to follicular but not diffuse large B-cell non-Hodgkin's lymphoma or multiple myeloma. Br J Haematol 2003; 120: 1051–1054
   PubMed Web of Science ®Google Scholar
• Gemmati D, Ongaro A, Scapoli G L, Della Porta M, Tognazzo S, Serino M L, et al. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults. Cancer Epidemiol Biomarkers Prev 2004; 13: 787–794
   PubMed Web of Science ®Google Scholar
• Gadner H, Masera G, Schrappe M, Eden T, Benoit Y, Harrison C, et al. The 8th International Childhood Acute Lymphoblastic Leukemia Workshop (‘Ponte di legno meeting’), Vienna, Austria, April 27 – 28, 2005. Leukemia 2006; 20: 9–17
   PubMed Web of Science ®Google Scholar
• Miller S A, Dykes D D, Polesky H F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215
   PubMed Web of Science ®Google Scholar
• Yi P, Pogribny I, Jill James S. Multiplex PCR for simultaneous detection of 677 C → T and 1298 A → C polymorphisms in methylenetetrahydrofolate reductase gene for population studies of cancer risk. Cancer Lett 2002; 181: 209
   PubMed Web of Science ®Google Scholar
• Matsuo K, Suzuki R, Hamajima N, Ogura M, Kagami Y, Taji H, et al. Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood 2001; 97: 3205–3209
   PubMed Web of Science ®Google Scholar
• Lightfoot T J, Skibola C F, Willett E V, Skibola D R, Allan J M, Coppede F, et al. Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing genes. Cancer Epidemiol Biomarkers Prev 2005; 14: 2999–3003
   PubMed Web of Science ®Google Scholar
• Skibola C F, Forrest M S, Coppede F, Agana L, Hubbard A, Smith M T, et al. Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood 2004; 104: 2155–2162
   PubMed Web of Science ®Google Scholar
• Franco R F, Simoes B P, Tone L G, Gabellini S M, Zago M A, Falcao R P. The methylenetetrahydrofolate reductase C677T gene polymorphism decreases the risk of childhood acute lymphocytic leukaemia. Br J Haematol 2001; 115: 616–618
   PubMed Web of Science ®Google Scholar
• Wiemels J L, Smith R N, Taylor G M, Eden O B, Alexander F E, Greaves M F. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci USA 2001; 98: 4004–4009
   PubMed Web of Science ®Google Scholar
• Balta G, Yuksek N, Ozyurek E, Ertem U, Hicsonmez G, Altay C, et al. Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia. Am J Hematol 2003; 73: 154–160
   PubMed Web of Science ®Google Scholar
• Oliveira E, Alves S, Quental S, Ferreira F, Norton L, Costa V, et al. The MTHFR C677T and A1298C polymorphisms and susceptibility to childhood acute lymphoblastic leukemia in Portugal. J Pediatr Hematol Oncol 2005; 27: 425–429
   PubMed Web of Science ®Google Scholar
• Schnakenberg E, Mehles A, Cario G, Rehe K, Seidemann K, Schlegelberger B, et al. Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population. BMC Med Genet 2005; 6: 23
   PubMed Web of Science ®Google Scholar
• Pereira T V, Rudnicki M, Pereira A C, Pombo-de-Oliveira M S, Franco R F. 5,10-Methylenetetrahydrofolate reductase polymorphisms and acute lymphoblastic leukemia risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15: 1956–1963
   PubMed Web of Science ®Google Scholar
• Bender C M, Pao M M, Jones P A. Inhibition of DNA methylation by 5-aza-2′-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res 1998; 58: 95–101
   PubMed Web of Science ®Google Scholar
• Vidan-Jeras B, Jurca B, Dolzan V, Jeras M, Breskvar K, Bohinjec M. Caucasian Slovenian normal. HLA 1998, D W Gjertson, P I Terasaki. American society for histocompatibility and immunogenetics, Lenexa 1998; 180–181
   Google Scholar
• Faria-Neto J R, Chagas A C, Bydlowski S P, Lemos Neto P A, Chamone D A, Ramirez J A, et al. Hyperhomocystinemia in patients with coronary artery disease. Braz J Med Biol Res 2006; 39: 455–463
   PubMed Web of Science ®Google Scholar
• Meglic L, Stegnar M, Milanez T, Bozic M, Peterlin B, Peternel P, et al. Factor V Leiden, prothrombin 20210G → A, methylenetetrahydrofolate reductase 677C → T and plasminogen activator inhibitor 4G/5G polymorphism in women with pregnancy-related venous thromboembolism. Eur J Obstet Gynecol Reprod Biol 2003; 111: 157–163
   PubMed Web of Science ®Google Scholar
• Bohanec P, Dolzan V. Genetic polymorphisms of enzymes involved in folate metabolism in healthy Slovenian population. Zdrav Vestn 2004; 73: 807–813
   Google Scholar